• 83,000+ assets • Multilingual financial news • Actionable market insights
en-GB en
it it
en en
en-GB en-GB
nl nl
BUSINESS ART

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Co-developing immune-evasive allogeneic TCR-iPS-T-cell therapies for the treatment of solid tumors Co-developing immune-evasive allogeneic TCR-iPS-T-cell therapies for the treatment of solid tumors

globenewswire.com 30-05-2024 10:00 0.5 Minutes reading
Sentiment Bearish · 0/100
BearishBullish
Related news
rbi.org.in · 28.10.26 09:00

Money Market Operations as on October 27, 2026

Market operations BUSINESS MONEY
finra.org · 27.10.26 23:15

ATOMIC BROKERAGE LLC

BUSINESS